UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549

FORM 8-K

CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): November 19, 2019

CANFIELD MEDICAL SUPPLY, INC.
(Exact Name of Registrant as Specified in Its Charter)

  

COLORADO
(State or Other Jurisdiction of Incorporation)
 
000-55114     34-1720075  
  (Commission File Number)     (IRS Employer Identification No.)  
   
 

 

4120 Boardman-Canfield Road
Canfield, Ohio 44406

 
(Address of Principal Executive Offices)
 
(330) 533-1914
(Registrant's Telephone Number, Including Area Code)
 
 
(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

¨        Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨        Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨        Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨        Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class Trading Symbol Name of each exchange on which registered
     

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company [X]

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [X]

 

 

 

 
 

 

 

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

 

Resignation of Heather Kearns

 

On November 19, 2019, Heather Kearns tendered her resignation as Chief Executive Officer and Chief Financial Officer of Canfield Medical Supply, Inc. (the “Company”) effective immediately.

 

Appointment of John Matthias Lepo as interim Chief Executive Officer and Chief Financial Officer 

 

On November 20, the Board appointed John Matthias Lepo, a member of the Board, to serve as interim Chief Executive Officer and Chief Financial Officer of the Company until his successor is named by the Board.

 

Mr. Lepo, age 78, has since 1998 been President of Battersea Capital Inc. offering consulting services to small businesses including corporate finance and advisory functions as well as advising on businesses entering the public markets. Mr. Lepo has a Bachelor of Science in Economics from Saint Mary’s University of Minnesota.

 

There is no family relationship between Mr. Lepo and the Company’s officers and directors. Other than the employment terms described above, Mr. Lepo and the Company have not entered into any transaction, nor is any transaction proposed, which would require disclosure pursuant to Item 404(a) of Regulation S-K. 

 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: November 22, 2019

  CANFIELD MEDICAL SUPPLY, INC.
   
  /s/ John Matthias Lepo
 

By: John Matthias Lepo

Interim Chief Executive Officer and Chief Financial Officer